Akter S, Faruque M, Nahar K (2019) 168P association of serum IGF1 and adiponectin in prognosis of breast cancer metastasis. Ann Oncol 30:mdz100–mdz019

Article  Google Scholar 

Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T (2018) Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv Transl Res 8:1483–1507. https://doi.org/10.1007/s13346-018-0551-3

Article  PubMed  PubMed Central  Google Scholar 

Bahhnassy A, Mohanad M, Shaarawy S, Ismail MF, El-Bastawisy A, Ashmawy AM, Zekri A-R (2015) Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer. Mol Med Rep 12:851–864. https://doi.org/10.3892/mmr.2015.3560

Article  PubMed  PubMed Central  CAS  Google Scholar 

Belfiore A (2007) The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr Pharm Des 13:671–686. https://doi.org/10.2174/138161207780249173

Article  PubMed  CAS  Google Scholar 

Biello F, Platini F, D’Avanzo F, Cattrini C, Mennitto A, Genestroni S, Martini V, Marzullo P, Aimaretti G, Gennari A (2021) Insulin/IGF Axis in breast cancer: clinical evidence and translational insights. Biomolecules 11:125. https://doi.org/10.3390/biom11010125

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL (2010) Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy. Gynecol Oncol 116:92–98

Article  PubMed  CAS  Google Scholar 

Catimel G, Chauvin F, Guastalla JP, Rebattu P, Biron P, Clavelt M (1994) FAC (fluorouracil, doxorubicin, cyclophosphamide) as second line chemotherapy in patients with metastatic breast cancer progressing under FEC (fluorouracil, epirubicin, cyclophosphamide) chemotherapy. Ann Oncol 5:95–97

Article  PubMed  CAS  Google Scholar 

Duggan C, Wang C-Y, Neuhouser ML, Xiao L, Smith AW, Reding KW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R, McTiernan A (2013) Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. Int J Cancer 132:1191–1200. https://doi.org/10.1002/ijc.27753

Article  PubMed  CAS  Google Scholar 

Ekyalongo RC, Yee D (2017) Revisiting the IGF-1R as a breast cancer target. Npj Precision Onc 1:1–7. https://doi.org/10.1038/s41698-017-0017-y

Article  Google Scholar 

El-Haggar SM, El-Shitany NA, Mostafa MF, El-Bassiouny NA (2016) Metformin May protect nondiabetic breast cancer women from metastasis. Clin Exp Metastasis 33:339–357. https://doi.org/10.1007/s10585-016-9782-1

Article  PubMed  CAS  Google Scholar 

Essa NM, Elgendy MO, Gabr A, Mahmoud MM, Alharbi AA, Tashkandi HM, Salem HF, Harakeh S, Boshra MS (2023) The efficacy of Metformin as adjuvant to chemotherapy on IGF levels in non-diabetic female patients with progressive and non-progressive metastatic breast cancer. Eur Rev Med Pharmacol Sci 27:5200–5210. https://doi.org/10.26355/eurrev_202306_32638

Article  PubMed  CAS  Google Scholar 

Fumoleau P, Largillier R, Clippe C, Dieras V, Orfeuvre H, Lesimple T, Culine S, Audhuy B, Serin D, Cure H (2004) Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer. Eur J Cancer 40:536–542

Article  PubMed  CAS  Google Scholar 

Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, DeCensi A, Szabo E (2014) Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res 7:867–885

Article  CAS  Google Scholar 

Gennari A, Foca F, Zamarchi R, Rocca A, Amadori D, De Censi A, Bologna A, Cavanna L, Gianni L, Scaltriti L, Rossi E, Facchinetti A, Martini V, Bruzzi P, Nanni O (2020) Insulin-like growth factor-1 receptor (IGF-1R) expression on Circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the transmyme trial. Breast Cancer Res Treat 181:61–68. https://doi.org/10.1007/s10549-020-05596-4

Article  PubMed  CAS  Google Scholar 

Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51. https://doi.org/10.1200/JCO.2002.20.1.42

Article  PubMed  CAS  Google Scholar 

Hatoum D, McGowan EM (2015) Recent advances in the use of metformin: can treating diabetes prevent breast cancer? Biomed Res Int 2015:548436. https://doi.org/10.1155/2015/548436

Iams WT, Lovly CM (2015) Molecular pathways: clinical applications and future direction of Insulin-like growth Factor-1 receptor pathway Blockade. Clin Cancer Res 21:4270–4277. https://doi.org/10.1158/1078-0432.CCR-14-2518

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jellinger PS, Lebovitz HE, Davidson JA (2007) Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American diabetes association and the European association for the study of diabetes: response to Nathan et. Diabetes Care 30:e16–e17

Article  PubMed  Google Scholar 

Jones S, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E, Laufman L, Sundaram S, Urba WJ, Pritchard KI (2005) Randomized phase III study of docetaxel compared with Paclitaxel in metastatic breast cancer. J Clin Oncol 23:5542–5551

Article  PubMed  CAS  Google Scholar 

Karamouzis MV, Papavassiliou AG (2012) Targeting insulin-like growth factor in breast cancer therapeutics. Crit Rev Oncol Hematol 84:8–17. https://doi.org/10.1016/j.critrevonc.2012.02.010

Article  PubMed  Google Scholar 

Lei Y, Yi Y, Liu Y, Liu X, Keller ET, Qian C-N, Zhang J, Lu Y (2017) Metformin targets multiple signaling pathways in cancer. Chin J cancer 36:1–9

Article  Google Scholar 

Ling S, Song L, Fan N, Feng T, Liu L, Yang X, Wang M, Li Y, Tian Y, Zhao F (2017) Combination of Metformin and Sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway. Int J Oncol 50:297–309

Article  PubMed  CAS  Google Scholar 

Liu B, Fan Z, Edgerton SM, Yang X, Lind SE, Thor AD (2011) Potent anti-proliferative effects of Metformin on trastuzumab-resistant breast cancer cells via Inhibition of erbB2/IGF-1 receptor interactions. Cell Cycle 10:2959–2966. https://doi.org/10.4161/cc.10.17.16359

Article  PubMed  CAS  Google Scholar 

Le Marchand-Brustel Y, Heydrick SJ, Jullien D, Gautier N, Van Obberghen E (1995) Effect of insulin and insulin-like growth factor-1 on glucose transport and its transporters in soleus muscle of lean and obese mice. Metabolism 44:18–23

Article  PubMed  Google Scholar 

Martin JL, Baxter RC (1986) Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem 261:8754–8760

Article  PubMed  CAS  Google Scholar 

Martín M, Ruiz A, Muñoz M, Balil A, García-Mata J, Calvo L, Carrasco E, Mahillo E, Casado A, García-Saenz JÁ (2007) Gemcitabine plus Vinorelbine versus Vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish breast Cancer research group (GEICAM) trial. Lancet Oncol 8:219–225

Article  PubMed  Google Scholar 

Mathieu M-C, Clark GM, Allred DC, Goldfine ID, Vigneri R (1997) Insulin receptor expression and clinical outcome in node-negative breast cancer. Proceedings of the Association of American Physicians 109:565–571

Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, Kleinberg DL (2004) Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 89:2271–2274. https://doi.org/10.1210/jc.2003-032150

Article  PubMed  CAS  Google Scholar 

Morgillo F, De Vita F, Antoniol G, Orditura M, Auriemma PP, Diadema MR, Lieto E, Savastano B, Festino L, Laterza MM, Fabozzi A, Ventriglia J, Petrillo A, Ciardiello F, Barbarisi A, Iovino F (2013) Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer. Curr Oncol 20:e283–e288. https://doi.org/10.3747/co.20.1380

Article  PubMed  PubMed Central  CAS  Google Scholar 

Motallebnezhad M, Aghebati-Maleki L, Jadidi-Niaragh F, Nickho H, Samadi-Kafil H, Shamsasenjan K, Yousefi M (2016) The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies. Tumour Biol 37:11711–11721. https://doi.org/10.1007/s13277-016-5176-x